| |
Age |
BW |
Gender
(F/M) |
APACHE II |
Pre- ALB (g/dl) |
Post-ALB
(g/dl) |
|
| AT with ALB(N=11) |
78±4 (73-86) |
63 ±10 (49-67) |
4/7 |
30±4 |
2.5±0.7 |
2.8 ± 0.5 |
|
| AT without ALB (N=9) |
75±7 (69-80) |
60 ±9 (50-72) |
5/4 |
31±5 |
2.6±0.6 |
2.7 ± 0.6 |
|
| P values |
0.86 |
0.3 |
0.5 |
0.2 |
0.26 |
0.3 |
|
| |
PLAT.
(XlOOOO/uL) |
APTT (sec.) |
FIB.(mg/dl) |
FDP(ug/ml) |
PT(INR) |
CRP(mg/dl) |
SEPSIS (+) |
| AT with ALB (N=11) |
9.1±3 |
41±10 |
372±143 |
25±15 |
1.9±1.2 |
15.2±8 |
9/11 |
| AT without ALB (N=9) |
91.5±5 |
39±7 |
365±182 |
22±11 |
2.0±1.0 |
17.1±10 |
7/9 |
| P values |
0.4 |
0.24 |
0.43 |
0.5 |
0.65 |
0.56 |
0.55 |
|
| Pre-ALB: serum albumin levels before AT agent administration with or without 25% albumin solution; Post-ALB: serum albumin levels after AT agent administration with or without 25% albumin solution three days after the start of AT agent. The levels of the other parameters are those before the administration of the agent. Data are expressed mean ± SD. NS: not significant |
| Table 1: Demographic data of patients. |
